CSF2RB
Cytokine receptor common subunit beta
As of the edition of 20 October 2026, CSF2RB (cytokine receptor common subunit beta, UniProt P32927) has 2 drugs tested at it and 2 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P32927
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 10
- Disease areas
- Immune system; Bones, joints and muscles; Skin and connective tissue; Infections; Lungs and airways; Blood and lymph; Hormones; Nutrition and metabolism
- Registered trials of its drugs
- 11
Drugs at this target
| Status | Count |
|---|---|
| Went quiet | 1 |
| Stopped | 1 |
| Total | 2 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Mavrilimumab | Went quiet | Phase 2 | none listed |
| Cibinetide | Stopped | Phase 2 | none listed |
2 of 2 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 2 |
| Total on the list | 2 |